Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

bone metastasis

  • Open Access
    Evaluation of safety and dosimetry of 177Lu DOTA-ZOL for therapy of bone metastases
    Rene Fernandez, Elisabeth Eppard, Wencke Lehnert, Luis David Jimenez-Franco, Cristian Soza-Ried, Matias Ceballos, Jessica Ribbeck, Andreas Kluge, Frank Roesch, Marian Meckel, Konstantin Zhernosekov, Vasko Kramer and Horacio Amaral
    Journal of Nuclear Medicine January 8, 2021, jnumed.120.255851; DOI: https://doi.org/10.2967/jnumed.120.255851
  • You have access
    Total-Body 68Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan Guidelines
    Kelsey L. Pomykala, Johannes Czernin, Tristan R. Grogan, Wesley R. Armstrong, John Williams and Jeremie Calais
    Journal of Nuclear Medicine March 1, 2020, 61 (3) 405-411; DOI: https://doi.org/10.2967/jnumed.119.230318
  • You have access
    EBONI: A Tool for Automated Quantification of Bone Metastasis Load in PSMA PET/CT
    Jochen Hammes, Philipp Täger and Alexander Drzezga
    Journal of Nuclear Medicine July 1, 2018, 59 (7) 1070-1075; DOI: https://doi.org/10.2967/jnumed.117.203265
  • You have access
    Intended Versus Inferred Treatment After 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
    Bruce E. Hillner, Lucy Hanna, Rajesh Makineni, Fenghai Duan, Anthony F. Shields, Rathan M. Subramaniam, Ilana Gareen and Barry A. Siegel
    Journal of Nuclear Medicine March 1, 2018, 59 (3) 421-426; DOI: https://doi.org/10.2967/jnumed.117.205047
  • You have access
    Hospice Admission and Survival After 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
    Ilana F. Gareen, Bruce E. Hillner, Lucy Hanna, Rajesh Makineni, Fenghai Duan, Anthony F. Shields, Rathan M. Subramaniam and Barry A. Siegel
    Journal of Nuclear Medicine March 1, 2018, 59 (3) 427-433; DOI: https://doi.org/10.2967/jnumed.117.205120
  • You have access
    Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT
    Mohsen Beheshti, Alireza Rezaee, Hans Geinitz, Wolfgang Loidl, Christian Pirich and Werner Langsteger
    Journal of Nuclear Medicine October 1, 2016, 57 (Supplement 3) 55S-60S; DOI: https://doi.org/10.2967/jnumed.115.169730
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire